Quote:
Originally Posted by stomachmonkey
Why not?
Even the little **** prick ****tard said his product costs $1.00 or less to make.
They can certainly keep the price at or just above breakeven if they opt to forgo profit in favor of philanthropy.
Should not hurt them, everyone agrees there is a limited market for the product and it's only really profitable at exorbitant markup.
They would probably spend more in buying the resulting PR value than they lose by not making a profit on this one drug. |
If they are able to support their manufacturing with other products then they may be able to keep it at $1 for philanthropic reasons. I worked for a generic manufacturer years ago and we had to sell tetracycline for $.10 per capsule just to remain competitive. So it is possible. But there are tradeoffs.
__________________
Si non potes inimicum tuum vincere, habeas eum amicum and ride a big blue trike.
"'Bipartisan' usually means that a larger-than-usual deception is being carried out."
|